These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14733935)

  • 21. Rad23 ubiquitin-associated domains (UBA) inhibit 26 S proteasome-catalyzed proteolysis by sequestering lysine 48-linked polyubiquitin chains.
    Raasi S; Pickart CM
    J Biol Chem; 2003 Mar; 278(11):8951-9. PubMed ID: 12643283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural and functional characterization of the USP11 deubiquitinating enzyme, which interacts with the RanGTP-associated protein RanBPM.
    Ideguchi H; Ueda A; Tanaka M; Yang J; Tsuji T; Ohno S; Hagiwara E; Aoki A; Ishigatsubo Y
    Biochem J; 2002 Oct; 367(Pt 1):87-95. PubMed ID: 12084015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro assembly and recognition of Lys-63 polyubiquitin chains.
    Hofmann RM; Pickart CM
    J Biol Chem; 2001 Jul; 276(30):27936-43. PubMed ID: 11369780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging roles of ubiquitin in transcription regulation.
    Conaway RC; Brower CS; Conaway JW
    Science; 2002 May; 296(5571):1254-8. PubMed ID: 12016299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the importance of proteasome-interaction for Rad23 function.
    Lambertson D; Chen L; Madura K
    Curr Genet; 2003 Jan; 42(4):199-208. PubMed ID: 12589471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the C-terminal G3 domain in sorting and secretion of aggrecan core protein and ubiquitin-mediated degradation of accumulated mutant precursors.
    Domowicz MS; Pirok EW; Novak TE; Schwartz NB
    J Biol Chem; 2000 Nov; 275(45):35098-105. PubMed ID: 11063750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor alpha (PPARalpha ) turnover by the ubiquitin-proteasome system controls the ligand-induced expression level of its target genes.
    Blanquart C; Barbier O; Fruchart JC; Staels B; Glineur C
    J Biol Chem; 2002 Oct; 277(40):37254-9. PubMed ID: 12118000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-canonical ubiquitin-based signals for proteasomal degradation.
    Kravtsova-Ivantsiv Y; Ciechanover A
    J Cell Sci; 2012 Feb; 125(Pt 3):539-48. PubMed ID: 22389393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ZSCAN4 is negatively regulated by the ubiquitin-proteasome system and the E3 ubiquitin ligase RNF20.
    Portney BA; Khatri R; Meltzer WA; Mariano JM; Zalzman M
    Biochem Biophys Res Commun; 2018 Mar; 498(1):72-78. PubMed ID: 29477841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.
    Wallace AD; Cidlowski JA
    J Biol Chem; 2001 Nov; 276(46):42714-21. PubMed ID: 11555652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel in vitro assay for deubiquitination of I kappa B alpha.
    Strayhorn WD; Wadzinski BE
    Arch Biochem Biophys; 2002 Apr; 400(1):76-84. PubMed ID: 11913973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stable ubiquitination of human T-cell leukemia virus type 1 tax is required for proteasome binding.
    Chiari E; Lamsoul I; Lodewick J; Chopin C; Bex F; Pique C
    J Virol; 2004 Nov; 78(21):11823-32. PubMed ID: 15479824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubiquibodies, synthetic E3 ubiquitin ligases endowed with unnatural substrate specificity for targeted protein silencing.
    Portnoff AD; Stephens EA; Varner JD; DeLisa MP
    J Biol Chem; 2014 Mar; 289(11):7844-55. PubMed ID: 24474696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of the preferential ubiquitination site and ubiquitin-dependent degradation signal of Rpn4.
    Ju D; Xie Y
    J Biol Chem; 2006 Apr; 281(16):10657-62. PubMed ID: 16492666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ubiquitin-proteasome pathway.
    Roos-Mattjus P; Sistonen L
    Ann Med; 2004; 36(4):285-95. PubMed ID: 15224655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pVHL-independent ubiquitination of HIF1alpha and its stabilization by cobalt ion.
    Kanaya K; Kamitani T
    Biochem Biophys Res Commun; 2003 Jul; 306(3):750-5. PubMed ID: 12810083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization to the proteasome is sufficient for degradation.
    Janse DM; Crosas B; Finley D; Church GM
    J Biol Chem; 2004 May; 279(20):21415-20. PubMed ID: 15039430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S-adenosylmethionine decarboxylase degradation by the 26 S proteasome is accelerated by substrate-mediated transamination.
    Yerlikaya A; Stanley BA
    J Biol Chem; 2004 Mar; 279(13):12469-78. PubMed ID: 14718534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. UFD4 lacking the proteasome-binding region catalyses ubiquitination but is impaired in proteolysis.
    Xie Y; Varshavsky A
    Nat Cell Biol; 2002 Dec; 4(12):1003-7. PubMed ID: 12447385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel site for ubiquitination: the N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein.
    Breitschopf K; Bengal E; Ziv T; Admon A; Ciechanover A
    EMBO J; 1998 Oct; 17(20):5964-73. PubMed ID: 9774340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.